Capital Research Global Investors Zoetis Inc. Transaction History

Capital Research Global Investors

$443 Billion
Q2 2024

A detailed history of Capital Research Global Investors transactions in Zoetis Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 1,948,733 shares of ZTS stock, worth $380 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,948,733

Previous 4,050,681 51.89%

Holding current value

$380 Million

Previous $685 Million 50.71%

% of portfolio

0.08%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $306 Million - $376 Million	-2,101,948 Reduced 51.89%	1,948,733 $338 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $15 Million - $18.1 Million	90,330 Added 2.28%	4,050,681 $685 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $22.3 Million - $29.4 Million	-147,109 Reduced 3.58%	3,960,351 $782 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $11.8 Million - $13.6 Million	-70,325 Reduced 1.68%	4,107,460 $715 Million
Q2 2023 Aug 11, 2023	SELL	$160.94 - $186.23 $4.2 Million - $4.86 Million	-26,074 Reduced 0.62%	4,177,785 $719 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $44.2 Million - $53.2 Million	303,796 Added 7.79%	4,203,859 $700 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $76.2 Million - $91.6 Million	581,411 Added 17.52%	3,900,063 $572 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $101,726 - $125,229	686 Added 0.02%	3,318,652 $492 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $217,422 - $278,925	1,394 Added 0.04%	3,317,966 $570 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $272 Million - $350 Million	-1,497,105 Reduced 31.1%	3,316,572 $625 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $243,662 - $310,763	1,258 Added 0.03%	4,813,677 $1.17 Billion
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $281,852 - $312,228	-1,489 Reduced 0.03%	4,812,419 $934 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $22.3 Million - $26.9 Million	-143,050 Reduced 2.89%	4,813,908 $897 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $31 Million - $36.5 Million	215,381 Added 4.54%	4,956,958 $781 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $4.91 Million - $5.45 Million	31,239 Added 0.66%	4,741,577 $785 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $37 Million - $44.6 Million	269,743 Added 6.07%	4,710,338 $779 Million
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $91 Million - $116 Million	813,255 Added 22.42%	4,440,595 $609 Million
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $134 Million - $209 Million	1,444,228 Added 66.15%	3,627,340 $427 Million
Q4 2019 Feb 18, 2020	BUY	$116.25 - $133.25 $254 Million - $291 Million	2,183,112 New	2,183,112 $289 Million

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Zoetis Inc. Transaction History